Digital Meditation to Target Employee Stress: A Randomized Clinical Trial.
Read full paper →- Authors
- Radin RM, Vacarro J, Fromer E, Ahmadi SE, Guan JY, Fisher SM, Pressman SD, Hunter JF, Sweeny K, Tomiyama AJ, Hofschneider LT, Zawadzki MJ, Gavrilova L, Epel ES, Prather AA
- Journal
- JAMA Netw Open
- Year
- 2025
- Citations
- 7
TL;DR
A large randomized trial found that 10 minutes of daily app-based meditation for 8 weeks produced large reductions in perceived stress (Cohen d = 0.85) and small-to-moderate improvements in job strain, burnout, and work engagement among 1,458 healthcare employees, with effects largely maintained at 4-month follow-up.
What they tested
The researchers compared a digital mindfulness meditation program (Headspace app) against a waiting list control condition. The intervention group was instructed to complete 10 minutes of meditation per day for 8 weeks, starting with a "Basics" course (30 sessions on meditation fundamentals) followed by a "Letting Go of Stress" course (30 sessions on stress awareness and reframing negative emotions). Participants could use any courses they wished after completing these. The control group continued normal activities and was told not to start meditating during the study period.
The primary outcome was change in perceived stress at 8 weeks, measured by the Perceived Stress Scale (PSS, 0–40 scale, higher = more stress). Secondary outcomes included job strain (effort-reward imbalance), burnout (Bergen Burnout Inventory), work engagement (Utrecht Work Engagement Scale), subjective mindfulness (Mindfulness Attention Awareness Scale), depressive symptoms (PHQ-8), and anxiety symptoms (GAD-7). All outcomes were measured at baseline, 8 weeks, and 4 months.
Who was studied
The study included 1,458 employees (mean age 35.5 years, range 18+; 80.8% female) working at a single large academic medical center (University of California, San Francisco health system). All participants reported mild to moderate stress in the past month (PSS score ≥15 out of 40), had regular access to a web-enabled device, were fluent in English, and were not regular meditators (defined as having a sitting meditation practice fewer than 3 times per week in the past 3 months). Participants were recruited from May 2018 through September 2019 through flyers, staff events, and other passive recruitment methods.
The sample was predominantly White (59.1%), with 22.3% Asian, 5.3% Black or African American, 0.5% American Indian or Alaska Native, 0.3% Native Hawaiian or Pacific Islander, and 12.5% other or unknown. Hispanic or Latino ethnicity was reported by 14.6% of participants.
How they measured it
**Perceived Stress Scale (PSS):** 10 items, 0–40 scale, higher = more stress. Measures how unpredictable, uncontrollable, and overloaded respondents find their lives over the past month. High reliability (Cronbach α = 0.85–0.89).
**Siegrist Effort-Reward Imbalance Scale:** 22 items measuring job strain as the ratio of perceived effort (5 items, 5–25 scale) to perceived reward (11 items, 11–55 scale). Higher ratios = greater job strain. Also includes an overcommitment subscale (6 items, 6–24 scale). High reliability (α = 0.81).
**Bergen Burnout Inventory (BBI):** 9 items, mean score 1–6, higher = more burnout. Measures exhaustion, cynicism, and inadequacy at work. High reliability (α = 0.84).
**Utrecht Work Engagement Scale (UWES):** 9 items, mean score 1–6, higher = more engagement. Measures vigor, dedication, and absorption. High reliability (α = 0.89).
**Mindfulness Attention Awareness Scale (MAAS):** 15 items, mean score 1–6, higher = greater dispositional mindfulness. High reliability (α = 0.89).
**Patient Health Questionnaire (PHQ-8):** 8 items, 0–24 scale, higher = more depressive symptoms. High reliability (α = 0.82).
**Generalized Anxiety Disorder (GAD-7):** 7 items, 0–21 scale, higher = more anxiety symptoms. High reliability (α = 0.87).
**Treatment adherence:** Measured objectively by the Headspace app as mean meditation minutes per day.
Methodology
**Design:** This was a two-arm, parallel-group randomized clinical trial (RCT) with 1:1 allocation to digital meditation or waiting list control. Assessments occurred at baseline, 8 weeks (post-intervention), and 4 months (follow-up).
**Randomization:** The randomization sequence was generated by an online generator preprogrammed into Qualtrics survey software. The sequence was concealed until analysis. Randomization was not stratified by any participant characteristics and was triggered automatically upon completion of baseline assessments.
**Blinding:** This was an open-label trial. Participants knew which group they were in. Research assistants who tracked adherence and provided technical support were also unblinded. The authors state the randomization sequence was "concealed until analysis," but this refers to allocation concealment (preventing prediction of assignment), not blinding of participants or personnel. The outcome assessors (participants completing self-report questionnaires) were not blinded to condition.
**Duration:** The intervention period was 8 weeks. Follow-up assessments occurred at 4 months post-randomization (approximately 2 months after the intervention ended). Total study duration per participant was approximately 4 months.
**Statistical approach:** Primary analyses used intention-to-treat (ITT) principles, meaning all randomized participants were analyzed in their assigned groups regardless of adherence. The primary outcome was change in PSS score from baseline to 8 weeks, analyzed using linear mixed models. Effect sizes were reported as Cohen d (standardized mean difference). Secondary outcomes were analyzed similarly. Moderation analyses examined whether treatment adherence (minutes per day) predicted outcomes using linear regression. Data were analyzed from March 2023 to October 2024, meaning there was a 4–5 year gap between data collection completion (September 2019) and analysis.
**What this design can prove:** The RCT design with random allocation can establish causality—differences between groups at 8 weeks can be attributed to the meditation intervention rather than pre-existing differences. The large sample size (1,458) provides adequate statistical power to detect even small effects. Objective adherence tracking (app data) is a strength over self-reported meditation practice.
**What this design cannot prove:** The waiting list control cannot control for placebo effects, attention effects, or expectancy effects—participants who signed up for a meditation study and got the app likely expected to benefit, while controls expected no benefit. The lack of blinding means all outcomes (which were self-report) are vulnerable to demand characteristics and social desirability bias. The single-site design (one medical center) limits generalizability. The 4-month follow-up cannot speak to longer-term maintenance. The waiting list design also means controls knew they would eventually get the app, which could affect their responses.
**Major methodological weaknesses:** (1) No active control group (e.g., a sham meditation app or an alternative stress-reduction activity), so the specific effects of meditation cannot be separated from general engagement in a wellness activity. (2) No blinding of participants or assessors. (3) All outcomes are self-report—no objective measures of stress (e.g., cortisol, heart rate variability, blood pressure). (4) The 4–5 year delay between data collection and analysis is unusual and unexplained. (5) The control group was instructed not to meditate, but adherence to this instruction was not verified. (6) The study was funded by the app developer (Headspace, Inc.), though the authors state the funder had no role in design, analysis, or publication.
Key findings
**Primary outcome – Perceived stress at 8 weeks:**
Meditation group showed significantly greater reduction in PSS scores compared to waiting list control (Cohen d = 0.85; 95% CI, 0.73–0.96). This is a large effect size.
This improvement was largely maintained at 4-month follow-up (Cohen d = 0.71; 95% CI, 0.59–0.84).
**Secondary outcomes at 8 weeks (all favoring meditation):**
Job strain (effort-reward imbalance): Cohen d = 0.34 (95% CI, 0.23–0.46) — small-to-moderate effect
Job overcommitment: Cohen d = 0.33 (95% CI, 0.22–0.44) — small-to-moderate effect
Burnout (Bergen Burnout Inventory): Cohen d = 0.39 (95% CI, 0.28–0.50) — small-to-moderate effect
Work engagement (UWES): Cohen d = 0.28 (95% CI, 0.17–0.39) — small effect
Mindfulness (MAAS): Cohen d = 0.52 (95% CI, 0.41–0.63) — moderate effect
Depressive symptoms (PHQ-8): Cohen d = 0.47 (95% CI, 0.36–0.58) — moderate effect
Anxiety symptoms (GAD-7): Cohen d = 0.46 (95% CI, 0.35–0.57) — moderate effect
**Secondary outcomes at 4-month follow-up:**
Job strain: Cohen d = 0.37 (95% CI, 0.25–0.50) — maintained
Burnout: Cohen d = 0.37 (95% CI, 0.24–0.49) — maintained
Work engagement: Cohen d = 0.27 (95% CI, 0.15–0.40) — maintained
Mindfulness: Cohen d = 0.49 (95% CI, 0.36–0.61) — maintained
Depressive symptoms: Cohen d = 0.39 (95% CI, 0.27–0.52) — maintained
Anxiety symptoms: Cohen d = 0.37 (95% CI, 0.24–0.49) — maintained
**Adherence moderation:**
Participants who used the app 5–9.9 minutes per day showed greater stress reduction than those using it less than 5 minutes per day (mean PSS score difference: −6.58 points; 95% CI, −7.44 to −5.73).
The paper does not report the mean adherence rate or what proportion of participants met the 10-minute target.
Effect magnitude
The primary effect (Cohen d = 0.85 for perceived stress) is considered large by conventional standards. To put this in concrete terms: the average person in the meditation group moved from about the 50th percentile of stress to about the 80th percentile of the control group's stress distribution—meaning their stress dropped substantially relative to controls. The PSS has a range of 0–40, and a Cohen d of 0.85 corresponds to roughly a 4–5 point difference between groups (based on typical PSS standard deviations of 5–6 points in similar populations). This is roughly equivalent to moving from "moderate stress" (scores 15–20) to "low stress" (scores 10–14) on the PSS.
For job strain, the effect was smaller (d = 0.34), meaning about a 1–2 point difference on the effort-reward ratio scale. This is comparable to the effect of a moderate workplace wellness program or a 10% reduction in work hours.
For depressive symptoms (d = 0.47), the effect is roughly equivalent to a 2–3 point drop on the PHQ-8 (0–24 scale), which is clinically meaningful—comparable to the effect of some antidepressant medications in mild depression.
Limitations
**Acknowledged by authors:**
Waiting list control cannot control for placebo effects or non-specific treatment effects (attention, expectation, social support from research staff)
Single-site study at one academic medical center limits generalizability to other workplaces
Self-report measures only, no objective stress biomarkers
No blinding of participants or research staff
The 4–5 year gap between data collection (2019) and analysis (2023–2024) is not explained
The COVID-19 pandemic occurred during the follow-up period for some participants (enrollment ended September 2019, 4-month follow-up would extend into early 2020), which could have affected stress levels differentially
**Additional limitations a critical reader would note:**
Industry funding: The study was funded by Headspace, Inc., which provided the app subscriptions. While the authors state the funder had no role in design or analysis, industry-funded meditation studies consistently show larger effects than independent studies.
No active control: Without a comparison to another stress-reduction activity (exercise, journaling, cognitive-behavioral techniques), we cannot know if meditation is specifically effective or if any structured wellness activity would produce similar benefits.
High attrition? The abstract reports 1,458 participants at baseline, but the full text (truncated) does not clearly report attrition rates at 8 weeks and 4 months. If dropout was high and differential between groups, results could be biased.
Self-selection bias: Participants volunteered for a meditation study, meaning they likely had positive attitudes toward meditation, which could inflate effects.
The sample was predominantly female (80.8%) and from healthcare, which may limit generalizability to male-dominated or non-healthcare workplaces.
The control group was told not to meditate, but this was not verified. Some controls may have started meditating on their own, which would reduce the apparent effect.
The adherence analysis comparing 5–9.9 min/day vs <5 min/day is a post-hoc comparison, not a pre-specified primary analysis, and may be subject to confounding (people who meditate more may differ in other ways from those who meditate less).
Practical takeaways
For someone running their own n=1 experiment:
**What to test:**
Test a daily 10-minute guided mindfulness meditation using a structured app (Headspace, Calm, Ten Percent Happier, or similar). Focus on the "Basics" course first (learning fundamentals), then move to stress-specific content.
Alternatively, test any consistent daily meditation practice of 5–10 minutes, as the study found benefits even at 5–9.9 minutes per day.
**Minimum meaningful duration:**
Run the experiment for at least 8 weeks. The study found effects at 8 weeks, with maintenance at 4 months. Shorter periods (2–4 weeks) may not produce detectable changes.
For maintenance, continue the practice at least 5 minutes daily. The study did not test what happens if you stop entirely after 8 weeks.
**What to measure (specific metrics):**
**Primary:** Perceived Stress Scale (PSS-10) – free online, takes 2 minutes. Measure weekly to track trajectory.
**Secondary:**
- PHQ-8 or PHQ-9 for depressive symptoms (weekly)
- GAD-7 for anxiety symptoms (weekly)
- A simple 1–10 daily stress rating ("How stressed do you feel right now?")
- Work engagement or job satisfaction (weekly)
- Mindfulness (MAAS or a simpler 1–10 "How mindful were you today?" rating)
**Objective measures (optional but valuable):** Heart rate variability (HRV) measured via a wearable (e.g., Oura ring, Apple Watch, Polar chest strap) – morning resting HRV is a proxy for stress resilience. Sleep quality (sleep onset latency, wake after sleep onset) via wearable.
**Key confounds to control for:**
**Expectation effects:** If you expect meditation to help, you may rate yourself as less stressed. Consider a blinded design where you compare meditation to an active control (e.g., 10 minutes of daily quiet sitting, listening to relaxing music, or doing a simple cognitive task). Randomize which you do first (crossover design) and don't check your ratings until after each 8-week block.
**Life events:** Major stressors (job change, relationship issues, health problems) can swamp any meditation effect. Track major life events weekly and note them in your data.
**Sleep:** Poor sleep increases stress. Track sleep duration and quality alongside meditation.
**Exercise and diet:** Both